Pan-Ras Activation Assay
Specifications | |
---|---|
Product Category: | Small GTPase Activation Assays |
Product Description
Small GTP-binding proteins (or GTPases) are a family of proteins that serve as molecular regulators in signaling transduction pathways. Ras, a 21 kDa protein, regulating a variety of biological response pathways that include cell growth, cell transformation and tumor invasion. Like other small GTPases, Ras regulates molecular events by cycling between an inactive GDP-bound form and an active GTP-bound form. In its active (GTP-bound) state, Ras binds specifically to the Ras-binding domain (RBD) of Raf1 to control downstream signaling cascades. The most notable members of the Ras subfamily are H-Ras, N-Ras and K-Ras, mainly for being implicated in many types of cancer.
Cell Biolabs’ Pan-Ras Activation Assay Kit utilizes Raf1 RBD Agarose beads to selectively isolate and pull-down the active forms of Ras (H-Ras, K-Ras, and N-Ras) from purified samples or endogenous lysates. Subsequently, the precipitated GTP-Ras is detected by western blot analysis using an Anti-pan-Ras Antibody.
Cell Biolabs’ Pan-Ras Activation Assay Kit provides a simple and fast tool to monitor the activation of Ras. The kit includes easily identifiable Raf1 RBD Agarose beads (Figure 1), pink in color, and a GTPase Immunoblot Positive Control for quick Ras identification.
Each kit provides sufficient quantities to perform 20 assays.
Product Citations
- Nakaoka, H. J. et al. (2016) NECAB3 promotes activation of hypoxia-inducible factor-1 during normoxia and enhances tumourigenicity of cancer cells. Sci Rep. 6:22784.
- Krencik, R. et al. (2015) Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci Transl Med. doi:10.1126/scitranslmed.aaa5645.
- Gall, J. M. et al. (2014) Conditional Knockout of Proximal Tubule Mitofusin 2 Accelerates Recovery and Improves Survival after Renal Ischemia. J Am Soc Nephrol.
- Nikolos, F. et al. (2014) ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling. Mol Cancer Res. 12:843-854.
- Ohashi, K. et al. (2012) Lung Cancers with Acquired Resistance to EGFR Inhibitors Occasionally Harbor BRAF Gene Mutations but Lack Mutations in KRAS, NRAS, or MEK1. PNAS. 109:E2127-E2133.
- Catalog Number
STA-400-CB - Supplier
Cell Biolabs - Size
- Shipping
Blue Ice